Catalyst Pharmaceutical Inc. (CPRX) Financials

Key financial figures for Catalyst Pharmaceutical Inc. (Q1 2026).

Revenue

$149M

Net Income

$64M

EPS

$0.52

Total Assets

$1.1B

Operating Cash Flow

$60M

Full income statement, balance sheet, and cash flow for Catalyst Pharmaceutical Inc. on SentiSense.